| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0002 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.19 | 0.0004 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0005 |